Combination therapy may potentially improve ovarian cancer patient outcomes

Study shines light on child deaths from birth defects
29 September 2021
Hippocampus is the brain’s storyteller
29 September 2021

Combination therapy may potentially improve ovarian cancer patient outcomes

A new study from University of Kentucky Markey Cancer researchers demonstrates a combination of two drugs may be useful to treat ovarian cancers that are resistant to paclitaxel.

Comments are closed.